Serotonergic involvement in stress-induced ACTH release

Brain Research

Volumn 811, Issue 1-2, 1998, Pages 10-20

  Jørgensen, Henrik ^a   Knigge, Ulrich ^a,b   Kjær, Andreas ^a   Vadsholt, Thomas ^a   Warberg, Jørgen ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ACTH; Neuroendocrine regulation; Serotonergic lesion; Serotonin; Serotonin metabolism; Stress

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 5 HYDROXYINDOLEACETIC ACID; CORTICOTROPIN; ESCHERICHIA COLI ENDOTOXIN; ETHER; KETANSERIN; METHYSERGIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ONDANSETRON; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; TROPISETRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; IMMOBILIZATION STRESS; MALE; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; SEROTONINERGIC NERVE CELL; STRESS; SWIMMING; THALAMUS MIDLINE NUCLEUS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; COLD; ETHER, ETHYL; HYDROXYINDOLEACETIC ACID; HYPOTHALAMUS; LIPOPOLYSACCHARIDES; MALE; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RESTRAINT, PHYSICAL; SECRETORY RATE; SEROTONIN; SEROTONIN ANTAGONISTS; STRESS;

EID: 0032539052     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00901-9     Document Type: Article

References (49)

1. Antoni F.A., Palkovits M., Makara G.B., Linton E.A., Lowry P.J., Kiss J.Z. Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract. Neuroendocrinology. 36:1983;415-423.
2. Azmitia-EC J., McEwen B.S. Adrenalcortical influence on rat brain tryptophan hydroxylase activity. Brain Res. 78:1974;291-302.
3. Azmitia E.C., Liao B., Chen Y.S. Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain. J. Neurosci. 13:1993;5041-5055.
4. Bagdy G., Calogero A.E., Murphy D.L., Szemeredi K. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology. 125:1989;2664-2669.
5. Beaulieu S., Di Paolo T., Barden N. Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback mechanism. Neuroendocrinology. 44:1986;247-254.
6. Berkenbosch F., van Oers J., del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 238:1987;524-526.
7. Besedovsky H.O., del Rey A. Immune-neuroendocrine circuits: integrative role of cytokines. Front. Neuroendocrinol. 13:1992;61-94.
8. Besedovsky H.O., del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17:1996;64-102.
9. Bockaert J., Fozard J.R., Dumuis A., Clarke D.E. The 5-HT4 receptor: a place in the sun. Trends Pharmacol. Sci. 13:1992;141-145.
10. Boess F.G., Martin I.L. Molecular biology of 5-HT receptors. Neuropharmacology. 33:1994;275-317.
11. Calogero A.E. Neurotransmitter regulation of the hypothalamic corticotropin-releasing hormone neuron. Ann. New York Acad. Sci. 771:1995;31-40.
12. Calogero A.E., Bernardini R., Margioris A.N., Bagdy G., Gallucci W.T., Munson P.J., Tamarkin L., Tomai T.P., Brady L., Gold P.W.et al. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides. 10:1989;189-200.
13. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
14. Chaouloff F., Laude D., Merino D., Serrurier B., Baudrie V., Elghozi J.L. Duration of streptozotocin diabetes influences the response of hypothalamic serotonin metabolism to immobilization stress. Neuroendocrinology. 50:1989;344-350.
15. Culman J., Kvetnansky R., Torda T., Murgas K. Serotonin concentration in individual hypothalamic nuclei of rats exposed to acute immobilization stress. Neuroscience. 5:1980;1503-1506.
16. De Souza E.B., Van Loon G.R. Brain serotonin and catecholamine responses to repeated stress in rats. Brain Res. 367:1986;77-86.
17. Dunn A.J., Welch J. Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J. Neurochem. 57:1991;1615-1622.
18. Feldman S., Conforti N., Melamed E. Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion. Brain Res. Bull. 18:1987;165-168.
19. Feldman S., Weidenfeld J. Depletion of hypothalamic norepinephrine and serotonin enhances the dexamethasone negative feedback effect on adrenocortical secretion. Psychoneuroendocrinology. 16:1991;397-405.
20. Fenger M. alpha-Melanocyte-stimulating-hormone precursors in the pig pituitary. Biochem. J. 235:1986;715-722.
21. Fletcher A., Forster E.A., Bill D.J., Brown G., Cliffe I.A., Hartley J.E., Jones D.E., McLenachan A., Stanhope K.J., Critchley D.J., Childs K.J., Middlefell V.C., Lanfumey L., Corradetti R., Laporte A.M., Gozlan H., Hamon M., Dourish C.T. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav. Brain Res. 73:1996;337-353.
22. Fukata J., Nakai Y., Imura H., Takeuchi J. Effects of serotonin depleters on the contents of beta-endorphin, alpha-melanotropin and adrenocorticotropin in rat brain and pituitary. Brain Res. 324:1984;289-293.
23. Fuller R.W., Snoddy H.D. Elevation of plasma corticosterone by swim stress and insulin-induced hypoglycemia in control and fluoxetine-pretreated rats. Endocr. Res. Commun. 4:1977;11-23.
24. Gartside S.E., Ellis P.M., Sharp T., Cowen P.J. Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments. Eur. J. Pharmacol. 221:1992;27-33.
25. Groenink L., Mos J., Van der Gugten J., Olivier B. The 5-HT1A receptor is not involved in emotional stress-induced rises in stress hormones. Pharmacol. Biochem. Behav. 55:1996;303-308.
26. Hoyer D. Functional correlates of serotonin 5-HT1 recognition sites. J. Recept. Res. 8:1988;59-81.
27. D. Hoyer, 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues, in: J. Fozard (Ed.), Peripheral Actions of 5-HT, Oxford Univ. Press, Oxford, 1989 pp. 72-99.
28. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
29. Ito H., Akuzawa S., Tsutsumi R., Kiso T., Kamato T., Nishida A., Yamano M., Miyata K. Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex. Neuropharmacology. 34:1995;631-637.
30. Jones M.T., Gillham B. Factors involved in the regulation of adrenocorticotropic hormone/beta-lipotropic hormone. Physiol. Rev. 68:1988;743-818.
31. Jorgensen H., Knigge U., Warberg J. Effect of serotonin 5-HT1, 5-HT2, and 5-HT3 receptor antagonists on the prolactin response to restraint and ether stress. Neuroendocrinology. 56:1992;371-377.
32. Lefebvre H., Contesse V., Delarue C., Soubrane C., Legrand A., Kuhn J.M., Wolf L.M., Vaudry H. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 77:1993;1662-1666.
33. Levy A.D., Li Q.A., Kerr J.E., Rittenhouse P.A., Milonas G., Cabrera T.M., Battaglia G., Alvarez Sanz M.C., Van de Kar L.D. Cocaine-induced elevation of plasma adrenocorticotropin hormone and corticosterone is mediated by serotonergic neurons. J. Pharmacol. Exp. Ther. 259:1991;495-500.
34. Li Q., Rittenhouse P.A., Levy A.D., Alvarez Sanz M.C., Van de Kar L.D. Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists. Neuropharmacology. 31:1992;983-989.
35. Molineaux S.M., Jessell T.M., Axel R., Julius D. 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc. Natl. Acad. Sci. USA. 86:1989;6793-6797.
36. Morgan W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone high specific activity. Nature. 194:1962;495-495.
37. Pazos A., Cortes R., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain: II. Serotonin-2 receptors. Brain Res. 346:1985;205-230.
38. Rittenhouse P.A., Bakkum E.A., O'Connor P.A., Carnes M., Bethea C.L., Van de Kar L.D. Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear. Brain Res. 580:1992;205-214.
39. Rivier C., Chizzonite R., Vale W. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology. 125:1989;2800-2805.
40. Rivier C., Vale W. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology. 113:1983;939-942.
41. Rivier C., Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature. 305:1983;325-327.
42. Saphier D., Farrar G.E., Welch J.E. Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists. Psychoneuroendocrinology. 20:1995;239-257.
43. Saphier D., Welch J.E. Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress. J. Neurochem. 64:1995;767-776.
44. Sawchenko P.E., Swanson L.W., Steinbusch H.W., Verhofstad A.A. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 277:1983;355-360.
45. Schreiber R., Brocco M., Audinot V., Gobert A., Veiga S., Millan M.J. (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J. Pharmacol. Exp. Ther. 273:1995;101-112.
46. Vahabzadeh A., Fillenz M. Comparison of stress-induced changes in noradrenergic and serotonergic neurons in the rat hippocampus using microdialysis. Eur. J. Neurosci. 6:1994;1205-1212.
47. Van de Kar L.D., Richardson Morton K.D., Rittenhouse P.A. Stress: neuroendocrine and pharmacological mechanisms. Methods Achiev. Exp. Pathol. 14:1991;133-173.
48. van Wijngaarden I., Tulp M.T., Soudijn W. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188:1990;301-312.
49. Weiner R.I., Ganong W.F. Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol. Rev. 58:1978;905-976.